This inventor holds 15 USPTO granted patents and 8 published patent applications and 1 EPO patent, primarily in Vaccine Development. Top assignees: Nitto-Denko Corporation, Notto Denko Corporation, Osaka University. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ibaraki, JP (2016)
- Osaka, JP (2018 - 2022)
Company Filing History:


Years Active: 2016-2022
Areas of Expertise:
Title: Kyohei Matsushita: Innovator in Immunity Induction and Vaccine Development
Introduction
Kyohei Matsushita is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of immunology and vaccine development, holding a total of 15 patents. His work focuses on enhancing immune responses and developing effective vaccine compositions.
Latest Patents
Matsushita's latest patents include an immunity induction-promoting composition and a vaccine pharmaceutical composition. The immunity induction-promoting composition is designed to safely and effectively induce cellular immune responses, utilizing an antimicrobial drug as its active ingredient. Additionally, his vaccine pharmaceutical composition for oral administration enables stable storage of an influenza virus antigen, along with a method for producing this composition.
Career Highlights
Throughout his career, Kyohei Matsushita has worked with notable organizations such as Nitto Denko Corporation and Osaka University. His innovative approaches have led to advancements in medical treatments and vaccine technologies.
Collaborations
Matsushita has collaborated with esteemed colleagues, including Daisuke Asari and Mitsuhiko Hori. These partnerships have further enriched his research and development efforts in the field of immunology.
Conclusion
Kyohei Matsushita's contributions to immunity induction and vaccine development highlight his role as a leading inventor in the medical field. His innovative patents and collaborations continue to influence advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile